Sanofi (France Medicine unit)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Provider of pharmaceuticals. The business unit produces the following pharamceutical products: Surgestone, Provames, Speciafoldine and Tredemine. Surgestone and Provames are used for women's health indications; Speciafoldine is used to treat macrocytic anemia; and Tredemine is a World Health Organization recognized essential medicine to treat tapeworm.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- France
Sanofi (France Medicine unit) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Sanofi (France Medicine unit)‘s full profile, request access.
Request full access to PitchBookSanofi (France Medicine unit) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Sanofi (France Medicine unit)‘s full profile, request access.
Request full access to PitchBook